Vertex Pharmaceuticals
$217.139876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$217.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$7.25 (-3.23%) Today
-$0.11 (-0.05%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell VRTX and other stocks, options, ETFs, and crypto commission-free!
About VRTX
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. Read More The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Employees
3,000
Headquarters
Boston, Massachusetts
Founded
1989
Market Cap
56.32B
Price-Earnings Ratio
48.22
Dividend Yield
—
Average Volume
2.74M
High Today
$224.18
Low Today
$215.57
Open Price
$219.43
Volume
1.71M
52 Week High
$249.85
52 Week Low
$163.68
Collections
VRTX News
Analyst Ratings
76%
of 25 ratings
Buy
76%
Hold
24%
Sell
0%
VRTX Earnings
$0.00
$0.57
$1.13
$1.70
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected Apr 28, After Hours